Benazepril on tissue angiotensin-converting enzyme and cellular proliferation in restenosis after experimental angioplasty

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 6, 1997, Pages 790-797

  Li, Jiang ^a   Wanchun, Chen ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Angiotensin converting enzyme; Benazepril; Proliferation cell nuclear antigen; Restenosis; Tissue

Indexed keywords

BENAZEPRIL; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HYPOTENSION; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BENZAZEPINES; BIOLOGICAL MARKERS; BLOOD PRESSURE; CELL DIVISION; CORONARY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HYPERPLASIA; MALE; PEPTIDYL-DIPEPTIDASE A; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; TUNICA INTIMA;

EID: 0031415181     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199712000-00014     Document Type: Article

References (33)

1. Califf RM, Fortin DF, Frid DJ, et al. Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991;17(suppl B):2B-13B.
2. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell prolifertion in normal and injured rat arterial wall. Circ Res 1991;68:450-6.
3. Powell JS, Clozel JP, Muller RK, et al. Inhibitors of angiotensin-converting enzyme prevent myointima proliferation after vascular injury. Science 1989;245:186-8.
4. The Multicenter European Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Circulation 1992; 86:100-10.
5. Faxon DP. Effect of high dose angiotensin converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:262-9.
6. Rakugi H, Wang DS, Dzau VJ, Pratt RE. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 1994;90:449-55.
7. Schibutani T, Kanda A, Ishigai Y, et al. Inhibitory effect of peridopril, a novel angiotensin-converting enzyme inhibitor, on neointima formation after balloon injury in rats and cholesterol-fed rabbits. J Cardiovasc Pharmacol 1994;24:509-16.
8. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenosis coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1994;74:223-31.
9. Glagov S. Intimai hyperplasia, vascular remodeling, and the restenosis problem. Circulation 1994;89:2888-91.
10. Isner J. Vascular remodeling: honey, I think I shrunk the artery. Circulation 1994;89:2937-41.
11. Johnston CI, Mendelsohn FA, Cubela RB, Jackson B, Kohzuki M, Fabris B. Inhibition of angiotensin converting enzyme in plasma and tissues: studies ex vivo after administration of ACE inhibitors. J Hypertens 1988;6(suppl):S17-22.
12. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
13. Friedland J, Silverstein E. A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976;66:416-24.
14. Shi ZR, Itzkowitz SH, Kim YS. A comparison of three immunoperoxidase techniques for antigen detection in colorectal carcinoma tissues. J Histochem Cytochem 1988;36:317-22.
15. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418-32.
16. Stadius ML, Rowan R, Fleischauer JF, Kernoff R, Billingham M, Gown AM. Time course and cellular characteristics of iliac artery response to acute balloon injury: an angiographie, morphometric, and immunocytochemical analysis in the cholesterol-fed New Zealand White rabbit. Atheroscler Thromb 1992;12:1267-73.
17. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991;17:433-9.
18. Moore S. Thromboatherosclerosis in normolipemic rabbits: a result of continued endothelial damage. Lab Invest 1973;29:478-87.
19. Bittl JA. Advances in coronary angioplasty. N Engl J Med 1996; 335:1290-302.
20. More RS, Rutty G, Underwood MJ, Brack MJ, Gershlick AH. Assessment of myointimal cellular kinetics in a model of angioplasty by means of proliferation cell nuclear antigen expression. Am Heart J 1994;128:681-6.
21. Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest 1994;93:339-46.
22. Morishita R, Gibbons GH, Elusion KE, et al. Evidence for direct local effect of angiotensin in vascular hypertrophy: in vivo gene transfer of angiotensin converting enzyme. J Clin Invest 1994;94:978-84.
23. Schunkert H, Dzau VJ, Tan SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990;86:1913-20.
24. Johnston CI, Mooser V, Sun Y, Fabris B. Changes in cardiac angiotensin converting enzyme after myocardial infarction and hypertrophy in rats. Clin Exp Pharmacol Physiol 1990;18:107-10.
25. Hirsch AT, Talsnecs CE, Schunkert H, Paul M, Dzau VJ. Tissue specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ Res 1991;69:475-82.
26. Kaplan HB, Taylor DG, Olson SC, Andrews LD. Quinapril: a preclinical review of the pharmacology, pharmacokinetics, and toxicology. Angiology 1989;40(pt 2):335-50.
27. Fabris B, Yamada H, Cubela R, Jackon B, Mendelsohn FAO, Johnston CI. Characterization of cardiac angiotensin converting enzyme (ACE) and in vivo inhibition following oral quinapril. Br J Pharmacol 1990;100:651-5.
28. 1 receptor antagonist: effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991;139:1291-6.
29. Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci USA 1995;92: 1137-41.
30. Lam LY, Lacoste L, Bourassa MG. Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation 1992;85:1542-7.
31. Huber KC, Schwartz RS, Edwards WD, et al. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in porcine coronary injury model. Am Heart J 1993;125: 695-701.
32. Huckle WR, Drag MD, Acker WR, et al. Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation 1996; 93:1009-19.
33. Schiffrin EL, Deng LY, Larochelle. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients. J Cardiovas Pharmacol 1994;24(suppl 3):S51-6.